Just my humble opinion here....I tend to think you are right on target. While I was hoping we would pull in a little better offer if it happened in the immediate timeframe, like was done...maybe $40 or approx...it sure does feel like we jumped the gun here somewhat, and should have waited for perhaps another year as additional catalysts could take place. I question the timing as we are selling into the teeth of one of the worst biotech market drubbings I remember. I will not be disappointed or upset if this deal goes through just as planned at this time as it is certainly quite profitable. However, in the spirit of old golf the rebel soul, I do plan to do the two things at my option and vote no on my shares and hold on to them just in case another unexpected dark-horse enters the race.